rs6694035

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001007553.3(CSDE1):​c.*1210A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0083 in 152,800 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0083 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 0 hom. )

Consequence

CSDE1
NM_001007553.3 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 3.29

Publications

4 publications found
Variant links:
Genes affected
CSDE1 (HGNC:29905): (cold shock domain containing E1) Enables RNA stem-loop binding activity. Involved in IRES-dependent viral translational initiation; nuclear-transcribed mRNA catabolic process, no-go decay; and stress granule assembly. Located in Golgi apparatus; cytosol; and plasma membrane. Part of CRD-mediated mRNA stability complex. [provided by Alliance of Genome Resources, Apr 2022]
NRAS (HGNC:7989): (NRAS proto-oncogene, GTPase) This is an N-ras oncogene encoding a membrane protein that shuttles between the Golgi apparatus and the plasma membrane. This shuttling is regulated through palmitoylation and depalmitoylation by the ZDHHC9-GOLGA7 complex. The encoded protein, which has intrinsic GTPase activity, is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase activating protein. Mutations in this gene have been associated with somatic rectal cancer, follicular thyroid cancer, autoimmune lymphoproliferative syndrome, Noonan syndrome, and juvenile myelomonocytic leukemia. [provided by RefSeq, Jun 2011]
NRAS Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: ClinGen, Genomics England PanelApp
  • Costello syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 1-114716959-T-C is Benign according to our data. Variant chr1-114716959-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 1202429.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00832 (1268/152370) while in subpopulation NFE AF = 0.0143 (972/68042). AF 95% confidence interval is 0.0135. There are 7 homozygotes in GnomAd4. There are 561 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1268 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001007553.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSDE1
NM_001007553.3
MANE Select
c.*1210A>G
3_prime_UTR
Exon 20 of 20NP_001007554.1O75534-1
CSDE1
NM_001242891.2
c.*1210A>G
3_prime_UTR
Exon 21 of 21NP_001229820.1O75534-4
CSDE1
NM_001130523.3
c.*1210A>G
3_prime_UTR
Exon 20 of 20NP_001123995.1O75534-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSDE1
ENST00000358528.9
TSL:1 MANE Select
c.*1210A>G
3_prime_UTR
Exon 20 of 20ENSP00000351329.4O75534-1
CSDE1
ENST00000438362.7
TSL:1
c.*1210A>G
3_prime_UTR
Exon 21 of 21ENSP00000407724.3O75534-1
CSDE1
ENST00000339438.10
TSL:1
c.*1210A>G
3_prime_UTR
Exon 19 of 19ENSP00000342408.6O75534-2

Frequencies

GnomAD3 genomes
AF:
0.00833
AC:
1268
AN:
152252
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00258
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00562
Gnomad ASJ
AF:
0.00865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00518
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0143
Gnomad OTH
AF:
0.00863
GnomAD4 exome
AF:
0.00233
AC:
1
AN:
430
Hom.:
0
Cov.:
0
AF XY:
0.00388
AC XY:
1
AN XY:
258
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00244
AC:
1
AN:
410
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
14
Other (OTH)
AF:
0.00
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00832
AC:
1268
AN:
152370
Hom.:
7
Cov.:
33
AF XY:
0.00753
AC XY:
561
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.00257
AC:
107
AN:
41582
American (AMR)
AF:
0.00562
AC:
86
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00865
AC:
30
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00518
AC:
55
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0143
AC:
972
AN:
68042
Other (OTH)
AF:
0.00854
AC:
18
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
72
145
217
290
362
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00497
Hom.:
0
Bravo
AF:
0.00791

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
18
DANN
Benign
0.85
PhyloP100
3.3
PromoterAI
0.073
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6694035; hg19: chr1-115259580; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.